ZHONGZHIPHARM 03737Hong Kong Stock Exchange

0.7353.29%( -0.025 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
ZHONGZHIPHARM (03737) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2015-07-13
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG989611085

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.04B40/112
Net Profit (Last FY)20.28M52/125
ROE (Last FY)1.58%51/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Lai Zhi Tian Executive Director
Lai Ying Feng Executive Director
Lai Ying Sheng Executive Director
Cao Xiao Jun Executive Director
Jiang Li Xia Non-Executive Director
Ng Kwun Wan Independent Non-Executive Director
Zhu Shangheng Independent Non-Executive Director
Zhou Dai Han Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-08-26.

About this page

This page shows ZHONGZHIPHARM (03737) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.